Prevalence of Transmitted HIV-1 Drug Resistance Remains Low in Guangxi, China, Eight Years after Scale-Up of Highly-Active Antiretroviral Therapy | Zendy

Guojian Li | Zendy; Shujia Liang | Zendy; Tim J. Harrison | Zendy; Zhenzhu Tang | Zendy; Zhiyong Shen | Zendy; Xueyan Wang | Zendy; Xinghua Wu | Zendy; Wei Liu | Zendy; Fuxiong Liang | Zendy; Liushuai Feng | Zendy; Jin-ye Yang | Zendy; ZhongLiao Fang | Zendy

Open Access

Prevalence of Transmitted HIV-1 Drug Resistance Remains Low in Guangxi, China, Eight Years after Scale-Up of Highly-Active Antiretroviral Therapy

Author(s) -

Guojian Li,

Shujia Liang,

Tim J. Harrison,

Zhenzhu Tang,

Zhiyong Shen,

Xueyan Wang,

Xinghua Wu,

Wei Liu,

Fuxiong Liang,

Liushuai Feng,

Jin-ye Yang,

ZhongLiao Fang

Publication year - 2014

Publication title -

intervirology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.641

H-Index - 61

eISSN - 1423-0100

pISSN - 0300-5526

DOI - 10.1159/000362366

Subject(s) - antiretroviral therapy , virology , drug resistance , human immunodeficiency virus (hiv) , hiv drug resistance , drug , medicine , china , biology , environmental health , viral load , pharmacology , microbiology and biotechnology , geography , archaeology

Highly-active antiretroviral therapy (HAART) was scaled up in Guangxi, China in 2005. The number of individuals receiving free HAART increased dramatically from June 2010 under the Guangxi Government's anti-HIV programme. We aimed to determine the prevalence of HIV-transmitted drug resistance (TDR) of Guangxi.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research